Ainos To Implement Consolidation Of Its Common Stock, Effective June 30, 2025

Author: Benzinga Newsdesk | June 26, 2025 11:02am

Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that it will implement a consolidation of its common stock ("stock consolidation"), effective at the opening of trading on June 30, 2025. This strategic action positions Ainos to attract broader institutional interest as it enters a commercial execution phase in the second half of 2025 and supports the Company's continued Nasdaq listing.

This action aligns with the Company's 2025 execution roadmap, as Ainos advances pilot programs of its AI-powered scent digitization platform, AI Nose, and clinical development of VELDONA®, its low-dose oral interferon, across both human and veterinary indications.

Posted In: AIMD AIMDW